Login to Your Account

Regulatory NEWS

The House Ways and Means Committee met July 19 to examine the government's efforts to tamp down on Medicare fraud, but legislation is in the works that would increase the penalties for Medicare fraud even as the DoJ announced a series of arrests related to more than $1.3 billion in Medicare fraud.

"The statute is silent" was the Health Resources and Services Administration's (HRSA) constant refrain Tuesday in a House subcommittee hearing on the growth and oversight of the 340B prescription drug discount program.

HONG KONG – After more than a decade of development, Maryland-based Tissuegene Inc. and its Asia licensee, Kolon Life Science Inc., received a bittersweet go-ahead from the South Korean authorities to market gene therapy drug Invossa-K.

More Regulatory Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: